Connor Ahearn
Areas of Focus
Overview
Connor Ahearn is a senior counsel in Crowell & Moring’s Washington, D.C. office and is a member of the firm’s Antitrust and Competition Group. Connor’s practice involves counseling clients on a wide range of antitrust issues, including compliance with the Hart-Scott-Rodino Act, identifying and coordinating foreign merger control filings, and evaluating and advising on competitive issues associate with mergers, acquisitions, and competitor collaborations.
Career & Education
- College of William & Mary, B.A., cum laude, 2010
- University of Virginia, J.D., 2017
- District of Columbia
- Virginia
Connor's Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Client Alert | 5 min read | 10.20.26
Client Alert | 5 min read | 10.13.26
Firm News | 5 min read | 08.20.26
Representative Matters
- Representing DIRECTV as antitrust counsel in its proposed acquisition of the DISH video distribution business from EchoStar, including leading the merger review process before DOJ and providing strategic counsel and advice in connection with the transaction.
- Representing United Technologies in connection with its $135 billion merger with The Raytheon Company, which The Deal named its 2020 "Deal of the Year," its $30 billion acquisition of Rockwell Collins, and its $16.5 billion acquisition of Goodrich.
- Advising DuPont De Nemours on international merger control notification obligations.
- Representing Gwinnett Health System in its merger with Northside Hospital.
- Representing United Technologies in its $30 billion acquisition of Rockwell Collins.
Connor's Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Client Alert | 5 min read | 10.20.26
Client Alert | 5 min read | 10.13.26
Firm News | 5 min read | 08.20.26
Recognition
- Best Lawyers: Ones to Watch in America: Antitrust Law and Litigation – Antitrust, Washington, DC, 2026—2027
Connor's Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Client Alert | 5 min read | 10.20.26
Client Alert | 5 min read | 10.13.26
Firm News | 5 min read | 08.20.26
Insights
Connor's Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Client Alert | 5 min read | 10.20.26
Client Alert | 5 min read | 10.13.26
Firm News | 5 min read | 08.20.26
